Mark Watson, MD, PhD, associate professor of pathology and immunology, and Ramaswamy Govindan, MD, professor of medicine, have received a five-year, $1.47 million grant from the National Cancer Institute for research titled “Genomic Harbingers of Brain Metastasis in Non-Small Cell Lung Cancer.”
A cancer odyssey Inspired by his childhood physicians, Ramaswamy Govindan, MD, knew at a young age what he wanted to become. Along the way, he has journeyed from his native India to the U.S. and helped to navigate the frontiers of cancer care.
Studying the most common type of lung cancer, researchers from The Cancer Genome Atlas have uncovered new mutations in a cell-signaling pathway that plays a role in forming tumors. The new knowledge may expand treatments for patients because drugs targeting some of these genetic changes already are available or are in clinical trials.